Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedApr 05, 2026
DataAggregated Company Financials
Companies113
  • 7D0.1%
  • 3M-18.3%
  • 1Y-11.3%
  • YTD-18.8%

The Personal Products industry has stayed flat over the last week. Unfortunately though, the industry is down 11% over the past 12 months. Looking forward, earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 Apr 2026US$73.9bUS$48.2bUS$613.9m20.2x120.3x1.5x
Tue, 03 Mar 2026US$95.1bUS$48.2bUS$839.5m21x113.2x2x
Thu, 29 Jan 2026US$95.3bUS$47.6bUS$350.0m22.3x272.4x2x
Sat, 27 Dec 2025US$90.9bUS$47.6bUS$351.2m22x258.8x1.9x
Mon, 24 Nov 2025US$82.6bUS$47.6bUS$517.3m22.2x159.6x1.7x
Wed, 22 Oct 2025US$90.6bUS$47.7bUS$307.8m20x294.2x1.9x
Fri, 19 Sep 2025US$95.1bUS$47.6bUS$304.0m21.8x312.9x2x
Sun, 17 Aug 2025US$100.1bUS$48.2bUS$531.1m20.7x188.6x2.1x
Tue, 15 Jul 2025US$101.1bUS$48.0bUS$109.5m17.4x923.3x2.1x
Thu, 12 Jun 2025US$95.1bUS$48.0bUS$126.0m17.4x754.8x2x
Sat, 10 May 2025US$92.2bUS$48.0bUS$94.0m16.9x980.4x1.9x
Mon, 07 Apr 2025US$81.8bUS$48.7bUS$556.6m20.9x146.9x1.7x
Wed, 05 Mar 2025US$94.0bUS$49.0bUS$331.4m26.7x283.6x1.9x
Fri, 31 Jan 2025US$98.8bUS$49.3bUS$1.5b26.4x67x2x
Sun, 29 Dec 2024US$97.8bUS$49.3bUS$1.5b27.3x66.3x2x
Tue, 26 Nov 2024US$102.2bUS$49.3bUS$1.5b29.4x69.4x2.1x
Thu, 24 Oct 2024US$104.5bUS$49.5bUS$1.6b25.5x64.7x2.1x
Sat, 21 Sep 2024US$107.3bUS$49.5bUS$1.6b22x65.6x2.2x
Mon, 19 Aug 2024US$111.1bUS$49.2bUS$2.0b27.1x55.5x2.3x
Wed, 17 Jul 2024US$108.9bUS$49.0bUS$2.4b22x45x2.2x
Fri, 14 Jun 2024US$111.7bUS$49.0bUS$2.4b23.5x46.1x2.3x
Sun, 12 May 2024US$122.0bUS$48.8bUS$2.5b25.3x49.6x2.5x
Tue, 09 Apr 2024US$125.9bUS$48.8bUS$2.5b25.7x49.7x2.6x
Thu, 07 Mar 2024US$129.1bUS$49.0bUS$2.5b29.4x52.4x2.6x
Sat, 03 Feb 2024US$127.5bUS$50.1bUS$2.6b24.3x50x2.5x
Mon, 01 Jan 2024US$129.9bUS$49.9bUS$2.6b27.1x49.3x2.6x
Wed, 29 Nov 2023US$114.3bUS$49.9bUS$2.6b24.2x43.9x2.3x
Fri, 27 Oct 2023US$112.5bUS$50.0bUS$3.3b23.2x34.2x2.2x
Sun, 24 Sep 2023US$124.4bUS$50.0bUS$3.3b24.1x37.9x2.5x
Tue, 22 Aug 2023US$133.5bUS$49.8bUS$3.0b21.6x45.2x2.7x
Thu, 20 Jul 2023US$149.6bUS$49.2bUS$3.2b22.4x46.7x3x
Sat, 17 Jun 2023US$156.4bUS$49.3bUS$3.1b22.3x49.9x3.2x
Mon, 15 May 2023US$153.1bUS$48.9bUS$3.3b23.9x47x3.1x
Wed, 12 Apr 2023US$119.6bUS$34.5bUS$1.7b17.9x71.3x3.5x
Price to Earnings Ratio

71.3x


Total Market Cap: US$119.6bTotal Earnings: US$1.7bTotal Revenue: US$34.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 167.9x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 116x which is lower than its 3-year average PE of 168x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 28% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market3.46%
Consumer Staples1.41%
Personal Products0.14%
Personal Products0.14%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$69.122.8%
+US$683.7m		30.6%PS1.7x
BRBR BellRing BrandsUS$16.628.3%
+US$148.9m		-76.2%PE10.7x
COTY CotyUS$2.052.5%
+US$44.0m		-59.3%PS0.3x
ODD Oddity TechUS$13.864.8%
+US$36.3m		-63.5%PE7.1x
YSG Yatsen HoldingUS$3.055.5%
+US$15.0m		-28.6%PS0.5x

Latest News

FTLF
US$10.61
FitLife Brands
7D
-25.7%
1Y
2.0%
NUS
US$7.41
Nu Skin Enterprises
7D
3.9%
1Y
15.1%
MTEX
US$5.79
Mannatech
7D
-16.7%
1Y
-30.7%
HNST
US$2.82
Honest Company
7D
-2.1%
1Y
-32.5%

HNST: Consistent Execution And Buybacks Will Support Future Margin Upside

Analysts trimmed their price target on Honest Company to $3.50, down from prior targets of $4 to $6. They cited Q4 results that came in slightly below Street expectations but within guidance, and a view that the company must show several quarters of consistent execution before shares can re-rate.
CABR
US$1.11
Caring Brands
7D
-10.5%
1Y
n/a
BRBR
US$16.62
BellRing Brands
7D
8.3%
1Y
-76.2%

BRBR: Protein Adoption Theme Will Drive Returns Despite Tougher Category

The analyst fair value estimate for BellRing Brands has been adjusted from $22.00 to $19.00 as analysts recalibrate assumptions for revenue growth, profit margins, and future P/E multiples while still highlighting the broader shift toward convenient protein products. Analyst Commentary Street research around BellRing Brands points to a mixed setup for investors, with optimism about long term protein adoption sitting alongside a series of lower price targets and more guarded expectations for execution and growth.
SNYR
US$0.80
Synergy CHC
7D
-33.9%
1Y
-65.1%
ODD
US$13.86
Oddity Tech
7D
4.8%
1Y
-63.5%

ODD: Corrective Actions On Ad Partner Disruption Will Gradually Restore Market Confidence

Analysts have trimmed the Oddity Tech price target range, with the model fair value easing slightly and Street research citing higher customer acquisition costs, weaker user additions, and limited visibility after advertising platform disruptions as key reasons for the reset. Analyst Commentary Recent research shows a sharp reset in expectations for Oddity Tech, with many on the Street focusing on advertising disruptions, user acquisition costs, and weaker near term visibility.
COTY
US$2.05
Coty
7D
2.5%
1Y
-59.3%
HLF
US$13.89
Herbalife
7D
-3.6%
1Y
68.0%
YSG
US$3.05
Yatsen Holding
7D
5.5%
1Y
-28.6%

YSG: Convertible Notes Will Support Earnings Recovery And Share Price Upside

Analysts have kept their price target for Yatsen Holding broadly unchanged around $7.54, citing largely stable assumptions on revenue growth, profit margins and future P/E, while making only a minor adjustment to the discount rate used in their models. What's in the News Yatsen Holding plans a private placement of Senior Convertible Notes with an aggregate principal amount of US$120,000,000, paired with warrants to purchase Class A ordinary shares, under a purchase agreement dated March 11, 2026 (Key Developments).
EL
US$69.12
Estée Lauder Companies
7D
2.8%
1Y
30.6%

EL: Potential Puig Deal And New Fragrance Launch Will Support Future Upside

Analysts have trimmed their price targets for Estée Lauder Companies to around $106, reflecting slightly softer revenue growth assumptions, a marginally higher discount rate and a somewhat lower future P/E multiple, partly balanced by modestly stronger profit margin expectations. What's in the News Estée Lauder and Spanish beauty group Puig confirmed on March 23, 2026 that they are in discussions over a potential business combination that could create a company valued at more than US$40b, with no final agreement in place and no assurance that a transaction will occur (company statements, FT report).
KVUE
US$17.14
Kenvue
7D
-2.2%
1Y
-23.2%
SKIN
US$0.91
Beauty Health
7D
12.4%
1Y
-24.6%
WALD
US$0.90
Waldencast
7D
-8.3%
1Y
-64.6%
NAGE
US$4.38
Niagen Bioscience
7D
4.3%
1Y
-27.2%

NAGE: Core Demand And Injectables Will Support Future Upside Potential

Analysts have trimmed their price target on Niagen Bioscience to $13 from $14. This reflects updated models after Q4 results that pointed to steady demand in the core business and potential upside from the injectable segment.